Q&A: Favorite phage production equipment

Issue 323 | August 22, 2025
9 min read
Capsid and Tail

This week we’re trying something new — let’s call it Phage Community Q&A! You send us your questions, we send you off-the-cuff answers. This week, Jess shares her favorite phage-making equipment in response to a researcher who’s setting up a phage therapy center in her lab.

Special note: We will be taking a Capsid & Tail hiatus for the next few weeks — see you in late September!

Sponsor

Why don’t we have phage therapy yet? We want to understand why. On the Podovirus podcast, we interview people we think could have the answers.

🎙️ Most recent episode: Joe and Jessica interviewed Dr. Saima Aslam, clinical lead at IPATH about how her approach has evolved since 2017, why patient selection has become crucial, and the importance of phage researcher-clinician collaboration for designing trials that actually work.

🎧 Listen: Podovirus on Spotify

🎥 Watch: Podovirus on YouTube

Subscribe to Podovirus to get the next episodes.

💰 On deck: Next up, we’ll release our interview with Ross Rheingans-Yoo. He’s a biotech investor who thinks phage therapy and other personalized medicine fields could work if done differently. What would it take to make the economics work? How does he see the phage field, and how does he compare it to other medicines he’s considering investing in?

Urgent August 14, 2025

Urgent need for Burkholderia multivorans phages for CF patient in France

Phage Therapy Cystic Fibrosis

We are urgently seeking Burkholderia multivorans phages for a cystic fibrosis patient in France

Ways to help at this stage:

  • By sending your phages for testing on the patient’s strains
  • By receiving the patient’s strain and testing your phages
  • By helping spread the word about this request
  • By providing us with names/email addresses of labs you think we should contact

Please email [email protected] if you can help in any way, or if you would like further details/clarification.

Let’s make a difference,
Phage Directory

What’s New

Naia Novy (University of Wisconsin-Madison) and colleagues published a new paper on multiobjective machine learning design of phage specificity, showing deep learning can successfully design T7 phages with precisely tuned infectivity, specificity, and generality across diverse E. coli strains. They could even make T7 have the completely opposite host range compared to wild type, just by changing up its RBP according to the ML model’s suggested sequence!

PreprintMachine learningPhage engineering

Shelby Andersen (University of Colorado Anschutz Medical Campus) and colleagues published a new paper on systematic phage gene function interrogation, showing PhageMaP enables high-throughput screening of phage mutant libraries to decipher genotype-phenotype relationships.

Research paperBioinformatic toolHigh throughput

Zhiying Zhang (Memorial Sloan Kettering Cancer Center) and colleagues published a new paper on a membrane-embedded Kiwa defense supercomplex mechanism, showing KwaA and KwaB form transmembrane complexes that detect phage attachment and bind DNA to block replication without killing host cells.

Research paperPhage defense

Hannah Kapoor (Oregon State University) and colleagues published a new paper on phage-mediated TLR2 signaling against intracellular Mycobacterium abscessus, showing certain mycobacteriophages stimulate TLR2 signaling and NLRP3 inflammasome activation in macrophages, significantly reducing intracellular M. abscessus survival through enhanced innate immune responses.

Research paperPhage immune interactions

Amit Vikram (Intralytix) and colleagues published a new paper on phage cocktail biocontrol in wheat milling operations, showing significant E. coli O157:H7 reductions of 1.4-3.1 log CFU/g without affecting flour quality or baking properties.

Research paperPhage in food

Latest Jobs

InternPhage engineering
I’m Harshu (Biophysics MD-PhD @ Shipman Lab, UCSF) – looking for an undergraduate (anyone from bioengineering, biochemistry, MCB, computational bio, microbiology is welcome) to start sometime in September 2025.

Project description: re-engineering bacteriophages for therapeutic delivery applications. Ideal wet lab experience: molecular cloning (must), sterile technique, western blots, protein purification, cell culture (willing to consider people missing some of this though if they’re particularly motivated).

Please email [email protected] with a resume and a small blurb of why they’re interested!

Culture collectionScientist
ATCC (Gaithersburg, Maryland), the iconic nonprofit biological resources and standards organization, is hiring a Scientist, Biomedical Genomics, to contribute to the implementation and computational analysis of 'omics data and next-generation sequencing (NGS) projects.
Senior ScientistSynthetic biology
Invitris is hiring a Senior Scientist, to develop next-gen protein-based tech (like cell-free phage production!) in Munich.
Post DocMicrobial genetics
Lawrence Berkeley National Lab is hiring a Postdoctoral Fellow to study microbial genomics and engineered living materials for critical mineral recovery.

Community Board

Anyone can post a message to the phage community — and it could be anything from collaboration requests, post-doc searches, sequencing help — just ask!

Jessica was interviewed on the Development & Research podcast, a new video interview series by biotech investor/economist Ross Rheingans-Yoo about people doing things differently in clinical trials and drug development.

They discussed operational challenges with phage therapy in academic versus clinical settings, why most trials fail due to execution issues rather than fundamental problems with phages, and more!

Check out Development & Research’s other interviews on clinical drug trial inefficiencies and those building the solutions — they are excellent!

PodcastClinical trialsPhage therapy

The 6th International Conference on Bacteriophage Research & Antimicrobial Resistance is taking place November 12–13, 2025, in Varanasi, India.

Hosts: the Institute of Medical Sciences–Banaras Hindu University along with the Society for Bacteriophage Research and Therapy.

The conference aims to advance phage applications in health, environment, food, and antimicrobial resistance.

Abstracts are due September 10, 2025.

ConferencePhage applications

The Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) is coming up early next year on January 28-30, 2026 in Las Vegas.
 
The meeting will bring together the top scientists, innovators, and cross-sector leaders to address one of health care’s most resistant problems: AMR. But we can’t do that without your contributions.
 
ASM and IDSA are looking for the latest research across the innovation pipeline – from uncovering emerging resistance mechanisms to advancing next-generation therapeutics and accelerating translation into clinical studies.
 
Mark your calendar for the meeting (registration will open soon!) and begin preparing your abstract to submit by October 1, 2025. I hope to see you – and your research – at the meeting!

ConferenceAntimicrobial resistance

Q&A: Favorite phage production equipment

Profile Image
Phage microbiologist and co-founder of Phage Directory
Co-founderStaff Scientist
Phage Directory, Stanford University, Stanford, United States
Skills

Phage-host interactions, Phage Therapy, Phage manufacturing, Phage delivery

I’m a co-founder of Phage Directory and have a PhD in Microbiology from the University of Alberta (I studied Campylobacter phage biology). For Phage Directory, I help physicians find phages for their patients, and I’m always trying to find new ways to help the phage field grow (especially through connecting people and highlighting awesome stuff I see happening in the field).

I spent 2022-2024 as a postdoc in Jon Iredell’s group at Westmead Institute for Medical Research in Sydney, Australia, helping get Phage Australia off the ground. I helped set up workflows for phage sourcing, biobanking, diagnostics, production, purification and QC of therapeutic phage batches, and helped build data collection systems to track everything we did. We treated more than a dozen patients in our first year, and I’m so proud of that!

As of 2024, I joined the Bollyky lab at Stanford University as a Staff Scientist, where I’m focused on phage engineering and delivery (to both microbial and human cells) and hydrogel-embedded phage cocktail development for wounds!

This week I wanted to try something new. A Q&A from the phage community! Sometimes we get questions from labs, researchers, companies, about our thoughts or advice on a particular area of phage work.

Here’s a question I got from a researcher setting up a phage therapy center in their lab, and my (real, lightly edited for clarity) reply that I sent to her.

I thought I’d also share it here so all can benefit!

Question:

As you know, we are currently setting up a small-scale lab for personalized phage therapy production. I would be very grateful if you could share the specifications or recommendations for the equipment you used [during your time at Phage Australia], particularly the ultrafiltration (UF) system.

My answer:

Hi, thanks for asking! I love this question! The equipment I really like for phage production and quality control is:

For tangential flow filtration (TFF)

For column chromatography

  • AKTA Pure 25 (FPLC system; same as many use for protein purification - basically the base model is all you need, but there are various components you can choose between depending on how flexible you want to be)
  • Consumables:

For verifying endotoxin levels at the end

  • Nexgen endotoxin reader from Charles River - this is the best! And can buy FDA-approved cartridges. We just got one. (Regular price ~10k, we got a hefty discount, so I leapt at the chance; have to buy cartridges so each sample will cost around 40$ to test; therefore this reader is ideal for final product testing but not if you’re doing lots of samples as part of R&D)

If you have limited budget:

  • Instead of AKTA flux S, you can get a Sartorius Vivaflow (and secondhand or new peristaltic pump) (see Tiffany Luong’s awesome paper on this)
  • Instead of AKTA pure, you can use octanol (see Phage on Tap paper) to remove endotoxin — we did this for some of our patient preps in Australia, worked well; just use dialysis to remove octanol after)
  • Instead of Endotrap columns for AKTA pure, you can buy the gravity columns and not need the AKTA pure at all - this works well, just needs more time
  • Instead of Nexgen endotoxin reader, can use Biomerieux Endozyme II kit or similar - more laborious than Nexgen and not FDA approved, need to validate yourself / can be annoying to set up, but doable
  • Instead of TFF you can use Amicon spin columns (see Phage on Tap paper) and dialysis after you’ve got a purified prep

We are going through process of trying to get funding for these here at Stanford. That said, we are likely going to get Vivaflow cartridges and a peristaltic pump (1-3k online) instead of AKTA flux for now. And we already have an old AKTA Purifier (old model of the AKTA Pure) so we are using that for now - works great, just it may die and when it does, we will have no manufacturer support. We have the Nexgen reader now but also have the Endozyme II kit for when we have a lot of samples.

Hope this helps, happy to help if any of this is confusing! If you tell me your approximate budget I can suggest what you should choose among all those things.

Jessica

P.S. For those who want to dive deeper, here are the slides from a talk I gave on using TFF for phage purification at Evergreen 2025 (which just happened!) for the Phages for Global Health Phage Purification Workshop!

Send us your questions!

There you have it — our first Phage Community Q&A post. Let us know how you like this format so far!

And if you have your own question, or something you want advice on in the phage lab (or computational space), or a piece of equipment you want advice on before you buy, email us at [email protected]! We might not know, but we’ll see if we can get your question answered by someone in the phage field!

Capsid & Tail

Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.

We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.

Sign up for Phage Alerts

In collaboration with

Mary Ann Liebert PHAGE

Supported by

Leona M. and Harry B. Helmsley Charitable Trust

Crossref Member Badge